医学
肺纤维化
中医药
药品
重症监护医学
呼吸内科
肺病
药理学
纤维化
传统医学
病理
内科学
替代医学
外科
作者
Xianbo Wu,Jianli Huang,Jie Wang,Yihua Xu,Xinwei Yang,Minghan Sun,Jianyou Shi
标识
DOI:10.3389/fphar.2021.707491
摘要
Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to find new therapies and new drugs to replace the treatment of pulmonary fibrosis. In recent years, there have been a great number of research reports on the treatment of traditional Chinese medicine polysaccharides in various system fields. Among them, the treatment of PF has also gained extensive attention. This review summarized the source of polysaccharides, the drug activity of traditional Chinese medicine, and the protective effects on targets of Pulmonary fibrosis. We hope it can inspire researchers to design and develop polysaccharides, serving as a reference for potential clinical therapeutic drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI